Suppliers / Pierrel

Pierrel

Italy 172 employees Updated 9 July 2026

Pierrel is a finished-dose manufacturer based in Italy. It appears in 49 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, EMA and ANSM (FR). Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 23 March 2023 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
49
filings across 14 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 23 March 2023 VAI US FDA
  • 15 February 2019 VAI US FDA
  • 26 June 2018 NAI US FDA
  • 6 June 2014 VAI US FDA
  • 5 March 2012 VAI US FDA
  • 31 July 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Capua(CE), United Arab Emirates Not on file
CAPUA, Italy Not on file
Italy, Italy 3006999064
CE, Italy Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 10 None
EMA 7 6
ANSM (FR) 6 None
AIFA (IT) 6 None
SFDA (Saudi Arabia) 4 None
NCELS (KZ) 3 None

Questions about Pierrel

Does Pierrel hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Pierrel. It does have 49 filings with 14 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Pierrel FDA-registered?
One site operated by Pierrel carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Pierrel's last inspection go?
The most recent inspection on record closed on 23 March 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file.
Where does Pierrel manufacture?
4 registered sites are on record, in United Arab Emirates and Italy (Capua(ce), Capua and Italy among others). Every site is listed on this page with the register it came from.
Which regulators recognise Pierrel's GMP?
Current GMP certificates are on record from EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Pierrel comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 23 March 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates